6-K 1 dp87179_6k.htm FORM 6-K

 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
 SECURITIES EXCHANGE ACT OF 1934
 
For the month of February 2018
 
Commission File Number: 001-13742
 
ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)
 
Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)
 
                   Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
Form 20-F
 
Form 40-F
 
 
                   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
 
Yes
 
 
No
 
                   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
 
Yes
 
 
No
X
 

ISRAEL CHEMICALS LTD.
 
 INCORPORATION BY REFERENCE
 
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
 

ISRAEL CHEMICALS LTD.
 
 
1.
End of Tenure of Mr. Yaacov Dior, External Director of the Company
 

Item 1

End of Tenure of Mr. Yaacov Dior, External Director of the Company
 
The Company wishes to report, that Mr. Yaacov Dior's tenure as an external director expired today. Mr. Dior served as an external director of the Company since October 5, 2011.

The Company’s Board of Directors expresses its thanks to Mr. Dior for his contribution to the Company and its accomplishments.
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Israel Chemicals Ltd.
 
 
 
By:
/s/ Kobi Altman
 
 
Name:
Kobi Altman
 
 
Title:
Chief Financial Officer
 
 
Israel Chemicals Ltd.
 
 
 
By:
/s/ Lisa Haimovitz
 
 
Name:
Lisa Haimovitz
 
 
Title:
Senior Vice President, Global General Counsel and Corporate Secretary
 
Date: February 26, 2018